IQGAP1 and melanoma: Our results highlight the relevance of cytoplasmic lncRNA for oncogenic signaling pathways, and suggest that MIRAT and its protein-binding partner IQGAP1 may serve as potential therapeutic targets in melanoma through their modulation of the MAPK pathway.